254 related articles for article (PubMed ID: 15754653)
1. [Prevalence of Proteus mirabilis strains in clinical specimens and evaluation of their resistance to selected antibiotics].
Sekowska A; Janicka G; Wróblewska J; Kruszyńska E
Pol Merkur Lekarski; 2004 Nov; 17(101):538-40. PubMed ID: 15754653
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of multidrug-resistant Proteus spp. strains in clinical specimens and their susceptibility to antibiotics].
Reśliński A; Gospodarek E; Mikucka A
Med Dosw Mikrobiol; 2005; 57(2):175-84. PubMed ID: 16134389
[TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics].
Sekowska A; Janicka G; Wojda M; Wróblewska J; Manysiak S
Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425
[TBL] [Abstract][Full Text] [Related]
5. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E
Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
Khan AU; Musharraf A
Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
[TBL] [Abstract][Full Text] [Related]
7. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
Shvidenko IG
Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
[TBL] [Abstract][Full Text] [Related]
8. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
[TBL] [Abstract][Full Text] [Related]
9. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study].
Gabastou JM; Chouaki T; Mangeot J; Zemir A; Manuel C; Lepitre M; Gravisse J; Cornel E; Denis-Jacquot N; Mahuzier G
Pathol Biol (Paris); 1995 Apr; 43(4):320-3. PubMed ID: 7567123
[TBL] [Abstract][Full Text] [Related]
10. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region.
Ahmed AM; Hussein AI; Shimamoto T
J Antimicrob Chemother; 2007 Feb; 59(2):184-90. PubMed ID: 17114173
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility of Proteus mirabilis urinary tract isolates from 1999 to 2005 at Nîmes University Hospital].
Mahamat A; Lavigne JP; Bouziges N; Daurès JP; Sotto A
Pathol Biol (Paris); 2006; 54(8-9):456-61. PubMed ID: 17030456
[TBL] [Abstract][Full Text] [Related]
12. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
13. [Phenotype characterisation of Enterococcus spp. strains isolated from urocultures].
Berceanu Văduva D; Muntean D; Velimirovici D; Licker M; Ionescu G; Rădulescu M; Adămuţ M; Horhat F; Piluţ M; Berceanu Văduva C; Drăgan S; Rada M; Moldovan R
Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):111-8. PubMed ID: 19326723
[TBL] [Abstract][Full Text] [Related]
14. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
15. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital.
Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F
Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867
[TBL] [Abstract][Full Text] [Related]
16. Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains.
Stock I
J Chemother; 2003 Feb; 15(1):12-26. PubMed ID: 12678409
[TBL] [Abstract][Full Text] [Related]
17. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
Cernohorská L; Chvílová E
Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):81-5. PubMed ID: 21780025
[TBL] [Abstract][Full Text] [Related]
18. [The susceptibility of Proteus mirabilis strains isolated from white stork (Ciconia ciconia)].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E; Kasprzak M; Jerzak L; Kamiński P
Med Dosw Mikrobiol; 2011; 63(2):139-44. PubMed ID: 22184908
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of clinical Proteus strains to antibiotics and their combinations].
Sheina EP; Arutcheva AA
Antibiotiki; 1978 May; 23(5):424-8. PubMed ID: 350143
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity to beta-lactam and aminoglycoside antibiotics of clinical Proteus strains as dependent upon on their species classification and the source of their isolation].
Shvidenko IG
Antibiot Med Biotekhnol; 1987 Nov; 32(11):850-5. PubMed ID: 3326520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
